UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 149 filers reported holding UNIQURE NV in Q2 2019. The put-call ratio across all filers is 0.24 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $648 | -99.9% | 56,584 | +145.4% | 0.05% | -29.0% |
| Q2 2021 | $710,000 | +65.9% | 23,060 | +94.9% | 0.07% | +50.0% |
| Q4 2020 | $428,000 | -51.6% | 11,833 | -39.7% | 0.05% | -54.9% |
| Q2 2020 | $884,000 | +22.1% | 19,614 | +6.6% | 0.10% | +82.1% |
| Q3 2019 | $724,000 | +49.3% | 18,399 | +196.6% | 0.06% | +100.0% |
| Q2 2019 | $485,000 | +1.7% | 6,204 | -22.5% | 0.03% | +3.7% |
| Q1 2019 | $477,000 | +12.2% | 8,001 | -31.6% | 0.03% | +3.8% |
| Q3 2018 | $425,000 | – | 11,689 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 841,471 | $15,786,000 | 5.69% |
| Nantahala Capital Management | 2,901,929 | $54,440,000 | 3.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 544,500 | $10,209,000 | 3.27% |
| 683 Capital Management, LLC | 1,373,600 | $25,768,000 | 1.99% |
| PFM Health Sciences, LP | 2,393,311 | $44,899,000 | 1.62% |
| Integral Health Asset Management, LLC | 433,000 | $8,123,000 | 1.58% |
| Privium Fund Management B.V. | 238,998 | $4,283,000 | 1.56% |
| Nantahala Capital Management | 1,000,000 | $18,760,000 | 1.21% |
| Henry James International Management Inc. | 89,469 | $1,678,000 | 0.94% |
| Altium Capital Management LP | 105,000 | $1,970,000 | 0.72% |